These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 30931765)
1. Is Antibiotic Prophylaxis Cost-effective for Dental Patients Following Total Knee Arthroplasty? Skaar DD; Park T; Swiontkowski MF; Kuntz KM JDR Clin Trans Res; 2019 Jan; 4(1):9-18. PubMed ID: 30931765 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of antibiotic prophylaxis for dental patients with prosthetic joints: Comparisons of antibiotic regimens for patients with total hip arthroplasty. Skaar DD; Park T; Swiontkowski MF; Kuntz KM J Am Dent Assoc; 2015 Nov; 146(11):830-9. PubMed ID: 26514888 [TBL] [Abstract][Full Text] [Related]
4. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis. Haentjens P; De Groote K; Annemans L Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of dental antibiotic prophylaxis in total knee arthroplasty recipients with type II diabetes mellitus. Stanley EE; Trentadue TP; Smith KC; Sullivan JK; Thornhill TS; Lange J; Katz JN; Losina E Osteoarthr Cartil Open; 2020 Dec; 2(4):100084. PubMed ID: 36474886 [TBL] [Abstract][Full Text] [Related]
6. Prescribing practices for antibiotic prophylaxis in patients with prosthetic joints. Teixeira EC; Warren JJ; McKernan SC; McQuistan MR; Qian F Spec Care Dentist; 2020 Mar; 40(2):198-205. PubMed ID: 31965592 [TBL] [Abstract][Full Text] [Related]
7. Can Technology Assistance be Cost Effective in TKA? A Simulation-Based Analysis of a Risk-prioritized, Practice-specific Framework. Hickey MD; Masri BA; Hodgson AJ Clin Orthop Relat Res; 2023 Jan; 481(1):157-173. PubMed ID: 36073992 [TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness of Bariatric Surgery Prior to Total Knee Arthroplasty in the Morbidly Obese: A Computer Model-Based Evaluation. McLawhorn AS; Southren D; Wang YC; Marx RG; Dodwell ER J Bone Joint Surg Am; 2016 Jan; 98(2):e6. PubMed ID: 26791039 [TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of Surgical and Nonsurgical Treatments for Unicompartmental Knee Arthritis: A Markov Model. Kazarian GS; Lonner JH; Maltenfort MG; Ghomrawi HMK; Chen AF J Bone Joint Surg Am; 2018 Oct; 100(19):1653-1660. PubMed ID: 30277995 [TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of access to musculoskeletal care: the case of waiting for total knee arthroplasty. Mather RC; Hug KT; Orlando LA; Watters TS; Koenig L; Nunley RM; Bolognesi MP BMC Musculoskelet Disord; 2014 Jan; 15():22. PubMed ID: 24438051 [TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of patellofemoral Chawla H; Nwachukwu BU; van der List JP; Eggman AA; Pearle AD; Ghomrawi HM Bone Joint J; 2017 Aug; 99-B(8):1028-1036. PubMed ID: 28768779 [TBL] [Abstract][Full Text] [Related]
12. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios. Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803 [TBL] [Abstract][Full Text] [Related]
13. Effect of age on cost-effectiveness of unicompartmental knee arthroplasty compared with total knee arthroplasty in the U.S. Ghomrawi HM; Eggman AA; Pearle AD J Bone Joint Surg Am; 2015 Mar; 97(5):396-402. PubMed ID: 25740030 [TBL] [Abstract][Full Text] [Related]
14. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation. Shepherd J; Jones J; Takeda A; Davidson P; Price A Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047 [TBL] [Abstract][Full Text] [Related]
15. Next-Generation Sequencing vs Culture-Based Methods for Diagnosing Periprosthetic Joint Infection After Total Knee Arthroplasty: A Cost-Effectiveness Analysis. Torchia MT; Austin DC; Kunkel ST; Dwyer KW; Moschetti WE J Arthroplasty; 2019 Jul; 34(7):1333-1341. PubMed ID: 31005439 [TBL] [Abstract][Full Text] [Related]
16. Surgical site infection prevention following total hip arthroplasty in Australia: a cost-effectiveness analysis. Merollini KM; Crawford RW; Whitehouse SL; Graves N Am J Infect Control; 2013 Sep; 41(9):803-9. PubMed ID: 23434381 [TBL] [Abstract][Full Text] [Related]
17. The Cost-Effectiveness of Robotic-Assisted Versus Manual Total Knee Arthroplasty: A Markov Model-Based Evaluation. Rajan PV; Khlopas A; Klika A; Molloy R; Krebs V; Piuzzi NS J Am Acad Orthop Surg; 2022 Feb; 30(4):168-176. PubMed ID: 35040808 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty. Schousboe JT; Brown GA J Bone Joint Surg Am; 2013 Jul; 95(14):1256-64. PubMed ID: 23864173 [TBL] [Abstract][Full Text] [Related]
19. Knee Joint Distraction Compared to Total Knee Arthroplasty for Treatment of End Stage Osteoarthritis: Simulating Long-Term Outcomes and Cost-Effectiveness. van der Woude JA; Nair SC; Custers RJ; van Laar JM; Kuchuck NO; Lafeber FP; Welsing PM PLoS One; 2016; 11(5):e0155524. PubMed ID: 27171268 [TBL] [Abstract][Full Text] [Related]